Skip to main content
. 2023 Jun 16;16(6):888. doi: 10.3390/ph16060888

Figure 5.

Figure 5

Docking of the most active dual FTIs/MTIs inhibitors in the tubulin binding site (colchicine site): (a) compound 1l—40% of the solutions; (b) compound 1l—60% of the solutions; (c) compound 3a; (d) compound 3e; (e) compound 3l; (f) phenstatin.